Click a link below to view the mailing archive as if it had been sent to you.
| 2015-04-30 12:15 | | Bayer says Xarelto isn't losing U.S. market share to Eliquis and more... |
| 2015-04-30 00:15 | | Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings and more... |
| 2015-04-29 12:15 | | FDA Policy: Is Off-Label on the Table? and more... |
| 2015-04-29 00:15 | | Pfizer reports uptake for cancer-therapy Ibrance and more... |
| 2015-04-28 12:15 | | Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A - bankers and more... |
| 2015-04-28 00:15 | | Medtronic to halt manufacture of pain drug pump -U.S. regulators and more... |
| 2015-04-27 12:15 | | Workers wanted: Seattle Genetics experiencing a growth spurt and more... |
| 2015-04-26 12:15 | | Swedish Orphan Said to Be Open to Sale Amid Boom in Drug Deals and more... |
| 2015-04-25 12:15 | | A Drug That Destroys Fat Cells Could Make Kythera's Stock Look Beautiful and more... |
| 2015-04-24 12:15 | | Biogen blueprints a big Phase III effort for its Alzheimer's hopeful and more... |
| 2015-04-24 00:15 | | Biogen Earnings Preview: What To Look For and more... |
| 2015-04-23 12:15 | | With GSK swap behind it, Novartis scouts for $2B-$5B buyouts and more... |
| 2015-04-23 00:15 | | Abbott says payoff from Mylan deal surges, as Mylan shares leap and more... |
| 2015-04-22 12:15 | | Roche more confident in beating Alzheimer's after Biogen data and more... |
| 2015-04-22 00:15 | | VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia and more... |
| 2015-04-21 12:15 | | Following a setback, Pfizer gets a win in Phase III cancer drug study and more... |
| 2015-04-21 00:15 | | Juno stock drops on report of lackluster immunotherapy results on solid tumors and more... |
| 2015-04-20 12:15 | | Is Teva considering a $34B Mylan buyout to offset Copaxone losses? and more... |
| 2015-04-20 00:15 | | Merck's Keytruda shrinks lung cancer tumors, FDA approval sought |
| 2015-04-19 12:15 | | Amarin: Vascepa Growth Moderates, But Long-Term Liquidity Still Appears Fine and more... |
| 2015-04-19 00:15 | | 5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015 and more... |
| 2015-04-18 12:15 | | Mylan skeptical of rumored Teva bid; hasn't received offer and more... |
| 2015-04-18 00:15 | | Sanofi and Innate Pharma team up on anticancer ADCs and more... |
| 2015-04-17 12:15 | | Benefits manager warns Vertex's cystic fibrosis Kalydeco combo too pricey and more... |
| 2015-04-17 00:15 | | FDA approves first generic version of Teva MS drug Copaxone and more... |
| 2015-04-16 12:15 | | Conventus Orthopaedics wins FDA clearance for shoulder fracture fixation device and more... |
| 2015-04-16 00:15 | | Will a New Vertex Drug for Cystic Fibrosis Become a Budget Buster? and more... |
| 2015-04-15 12:15 | | Novartis has fresh data to support newly acquired CCL drug Arzerra and more... |
| 2015-04-15 00:15 | | Takeda names U.S. head, currently its sole female executive and more... |
| 2015-04-14 12:15 | | GeoVax to Seek Dual Pathway for Advancing Its HIV Preventive Vaccine and more... |
| 2015-04-14 00:15 | | IBM launches new health unit, teams up with Apple, J&J, Medtronic and more... |
| 2015-04-13 12:15 | | Should The FDA Require CV Outcome Studies For Diabetes Drugs Before Approval? and more... |
| 2015-04-12 12:15 | | OvaScience: Beaten Down By Confusion And Misinformation and more... |
| 2015-04-11 12:15 | | Glaxo Plans Changes to Compensation Program for U.S. Sales Team and more... |
| 2015-04-11 00:15 | | Will Mylan's $29B bid spur other Perrigo suitors to enter the fray? and more... |
| 2015-04-10 12:15 | | Senate preps for medical device tax hearings and more... |
| 2015-04-10 00:15 | | A Threat to Drugmakers’ Hard Switch and more... |
| 2015-04-09 12:15 | | Pfizer dumps a hemophilia pact with Catalyst, threatening its Targacept merger and more... |
| 2015-04-09 00:15 | | Gilead’s $1,000 Pill Is Hard for States to Swallow and more... |
| 2015-04-08 12:15 | | A CEO's View On Cancer, Virus-Based 'Cures,' And '60 Minutes' Vs. Reality and more... |
| 2015-04-08 00:15 | | Pfizer wants Canadians to think EpiPen. What else but a hockey partnership? and more... |
| 2015-04-07 12:15 | | Will This EU Approval Move the Needle for Amgen? and more... |
| 2015-04-07 00:15 | | Clovis Jumps After Hours On Accelerated Review Of Ovarian Cancer Drug and more... |
| 2015-04-06 12:15 | | Why didn't J&J buy Imbruvica partner Pharmacyclics? It wants hot drugs cheap, CEO says and more... |
| 2015-04-04 12:15 | | Pfizer halts China vaccine sales after import licence not renewed and more... |
| 2015-04-03 12:15 | | Medtronic moves into healthcare management with latest deal and more... |
| 2015-04-03 00:15 | | Teva takes another swing at generic Copaxone with new FDA petition and more... |
| 2015-04-02 12:15 | | BMJ: Novartis tried to 'scupper' trials to protect Lucentis from cheap Avastin and more... |
| 2015-04-02 00:15 | | NuVasive CEO Lukianov resigns after reimbursement probe and more... |
| 2015-04-01 12:15 | | Pharma’s Comeback Deals Keep Drug M&A on Track to Reach Records and more... |
| 2015-04-01 00:15 | | Is the FDA Worried About Vertex's New Drug? and more... |
